glp 1 drugs compounded GLP-1 Compounding: When Innovation May Mean Liability Compounded versions of weight loss

In all observational studies, GLP-1 RAs were used as adjuncts to standard IIH care with nearly all patients also receiving acetazolamide

doi: 10.1016/j.diabres.2012.10.017

Fatty acid utilization in the hypertrophied and failing heart: molecular regulatory mechanisms

Our 2030 estimates contemplate global penetration into the addressable type 2 diabetes and obesity markets of only 8% and 2%, respectively (from about 3% and 0.2% in 2023). Uptake would likely be greater if these drugs could be consumed in oral form rather than injected, adds the report, An oral weight loss agent would likely be well-received in the primary care setting and could alleviate pressure on supply chains